Bristol-Myers Squibb Company (BMY)

NYQ – Цена в реальном времени. Валюта: USD

63.71

+0.10 (0.16%)

При закрытии: Aug 12, 2026, 3:59 PM EDT

63.67

-0.03 (-0.05%)

После закрытия: Aug 12, 2026, 6:29 PM EDT

12.08.2026

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

Bristol Myers growth portfolio now accounts for 56% of revenues, led by key drugs, including Opdivo Qvantig, Reblozyl and Breyanzi, helping offset generic erosion.

10.08.2026

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers Squibb's Growth Portfolio and pipeline support momentum, but generic headwinds and recent gains call for a cautious stance.

10.08.2026

Bristol Myers to build $2.3 billion manufacturing site in Houston

Drugmaker Bristol Myers Squibb on Monday said it will spend about $2.3 billion to build a new manufacturing facility in Houston, Texas, part of a previously announced $40 billion ‌commitment to invest in the United States.

10.08.2026

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas.

06.08.2026

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

05.08.2026

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

NEW YORK--(BUSINESS WIRE)-- #AgenticAI--Schrödinger, Inc. announced a strategic agreement with BMS to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization.

05.08.2026

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential ‌deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers.

Видео

No Data

There is no data to display

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
BMY	Argus	Buy	undefined >> $75	August 5th 2026

Пресс-релизы

10.08.2026

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas.

05.08.2026

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

NEW YORK--(BUSINESS WIRE)-- #AgenticAI--Schrödinger, Inc. announced a strategic agreement with BMS to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization.

Bristol-Myers Squibb Company (BMY)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Bristol-Myers Squibb Company (BMY)

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Search stocks

Bristol-Myers Squibb Company (BMY)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Bristol-Myers Squibb Company (BMY)

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?

Bristol Myers to build $2.3 billion manufacturing site in Houston

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery